Results 31 to 40 of about 9,610,135 (197)

A total cost perspective of type 1 and 2 diabetes mellitus in two South African medical schemes servicing the public healthcare sector

open access: yes, 2021
ArticleBackground. Diabetes is increasingly becoming a public health concern in South Africa (SA). There are limited available data on the costs of diabetes. Objectives.
Opperman, A.M., De Klerk, M
core   +1 more source

Determining direct, indirect healthcare and social costs for diabetic retinopathy management: a systematic review

open access: yesBMC Ophthalmology
Introduction Diabetic retinopathy (DR) is a rapidly growing global public health threat; it affects 1 in 3 people with diabetes and is still the leading cause of blindness among the working-age population.
Mawdda Benhamza   +2 more
doaj   +1 more source

The cost of dementia in an unequal country: The case of Chile.

open access: yesPLoS ONE, 2017
We study the economic cost of dementia in Chile, and its variation according to socioeconomic status (SES). We use primary data from a survey of 330 informal primary caregivers who completed both a RUD-Lite and a socio-demographic questionnaire to ...
Daniel A Hojman   +5 more
doaj   +1 more source

Economic burden of multiple sclerosis in Slovakia — from 2015 to 2020

open access: yesBMC Health Services Research, 2022
Background Multiple sclerosis (MS) is a chronic, inflammatory disease of the central nervous system, commonly diagnosed during young adulthood. The proportion of direct and indirect costs of MS vary across settings.
Robert Babela, Judit Dugas
doaj   +1 more source

The influence of the attending physician on indirect graduate medical education costs

open access: yesAcademic Medicine, 1984
In the study reported here, the author compared the hospital charges of three groups of patients in one combined university/community hospital: private patients with a community attending physician; teaching patients with a community attending physician; and teaching patients with a faculty attending physician.
openaire   +3 more sources

Describing financial toxicity among cancer patients in different income countries: a systematic review and meta-analysis

open access: yesFrontiers in Public Health
BackgroundThere is limited evidence of financial toxicity (FT) among cancer patients from countries of various income levels. Hence, this study aimed to determine the prevalence of objective and subjective FT and their measurements in relation to cancer ...
Meram Azzani   +6 more
doaj   +1 more source

Estimates of Direct Medical and Indirect Costs Associated With COVID-19 Among U.S. Active Duty Army Soldiers

open access: yesMilitary Medicine, 2022
ABSTRACT Introduction This study estimated the direct medical and indirect costs associated with coronavirus disease 2019 (COVID-19) diagnoses among U.S. active duty (AD) Army service members (SMs). These cost estimates provide the U.S.
Forrest, Lanna   +6 more
openaire   +2 more sources

A longitudinal study to assess the cost incurred by patients undergoing treatment for tuberculosis in an urban slum community

open access: yesMAMC Journal of Medical Sciences, 2016
Objectives: The objective of the study was to estimate direct medical/nonmedical and indirect costs incurred by patients diagnosed with tuberculosis (TB) residing in an urban slum of Mumbai.
Tarun S Khandednath   +3 more
doaj   +1 more source

Beyond direct medical costs: what we miss when indirect costs are ignored

open access: yesJournal of Medical Economics
Health economic evaluations play a central role in reimbursement decisions and health technology assessment (HTA). However, most analyses focus primarily on direct medical costs, potentially underestimating the true burden of disease. This paper examines the role of indirect costs in the economic evaluation of health interventions and their ...
Urszula Religioni   +3 more
openaire   +2 more sources

Comparing the Analysis and Results of a Modified Social Accounting Matrix Framework with Conventional Methods of Reporting Indirect Non-Medical Costs [PDF]

open access: yesPharmacoEconomics, 2020
Assessing the societal perspective in economic evaluations of new interventions requires estimates of indirect non-medical costs caused by the disease. Different methods exist for measuring the labor input function as a surrogate for these costs. They rarely specify the effect of health on labor and who gains and who loses money.
Baudouin Standaert   +3 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy